|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.545 SEK | -2.12% |
|
-8.45% | +20.62% |
ExpreS2ion Biotech Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 0.972 million compared to SEK 3.4 million a year ago. Revenue was SEK 1.58 million compared to SEK 4.43 million a year ago.
Net loss was SEK 48.53 million compared to SEK 14.32 million a year ago. Basic loss per share from continuing operations was SEK 1.29 compared to SEK 0.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.62% | 11.91M | |
| -4.00% | 86.85B | |
| +2.76% | 40.16B | |
| -16.98% | 31.28B | |
| +57.86% | 25.27B | |
| -16.24% | 15.33B | |
| -9.12% | 11.96B | |
| -42.56% | 11.61B | |
| -17.10% | 11.69B | |
| +6.89% | 8.83B |
EXPRES2ION BIOTECH HOLDING AB 
